进行性骨化性纤维发育不良
异位骨化
骨化
软骨
转化生长因子
间质细胞
癌症研究
转基因
转基因小鼠
祖细胞
发病机制
医学
细胞生物学
化学
病理
内分泌学
生物
解剖
干细胞
基因
生物化学
作者
Xiao Wang,Fengfeng Li,Liang Xie,Janet L. Crane,Gehua Zhen,Yuji M. Mishina,Ruoxian Deng,Bo Gao,Hao Chen,Shen Liu,Ping Yang,Manman Gao,Manli Tu,Yiguo Wang,Mei Wan,Cunyi Fan,Xu Cao
标识
DOI:10.1038/s41467-018-02988-5
摘要
Acquired heterotopic ossification (HO) is a painful and debilitating disease characterized by extraskeletal bone formation after injury. The exact pathogenesis of HO remains unknown. Here we show that TGF-β initiates and promotes HO in mice. We find that calcified cartilage and newly formed bone resorb osteoclasts after onset of HO, which leads to high levels of active TGF-β that recruit mesenchymal stromal/progenitor cells (MSPCs) in the HO microenvironment. Transgenic expression of active TGF-β in tendon induces spontaneous HO, whereas systemic injection of a TGF-β neutralizing antibody attenuates ectopic bone formation in traumatic and BMP-induced mouse HO models, and in a fibrodysplasia ossificans progressive mouse model. Moreover, inducible knockout of the TGF-β type II receptor in MSPCs inhibits HO progression in HO mouse models. Our study points toward elevated levels of active TGF-β as inducers and promoters of ectopic bone formation, and suggest that TGF-β might be a therapeutic target in HO.
科研通智能强力驱动
Strongly Powered by AbleSci AI